"The HPV vaccine prevents cervical cancer by protecting against the high-risk HPV types," cancer researcher Ashish A.

This study found a steep decline in cervical cancer mortality among US women younger than 25 years between 2016 and 2021.

HPV or human papillomavirus, is an STD—a sexually transmitted disease, an infection passed from one person to another through ...

Cervical cancer deaths have plunged dramatically among women under age 25, and researchers at MUSC Hollings Cancer Center ...

A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than ...

While the HPV vaccine is often marketed in Iowa toward women, a health care professional says it’s important that young ...

In this modeling study, the cost-effectiveness and number needed to vaccinate of mid-adult human papillomavirus (HPV) vaccination improved when limited to those at higher risk for acquiring HPV ...

According to DelveInsight’s analysis, the human papillomavirus market is anticipated to increase during the forecast period (2024–2034), owing to the launch of emerging therapies and healthcare ...

And yet, unlike most other cancers, almost all these cases and deaths can be averted. We have powerful vaccines that can ...

This interesting study presents valuable information on how human cytomegalovirus (HCMV) infection disrupts the activity of the TEAD1 transcription factor, leading to widespread chromatin alterations.

Researchers found a reduction in cervical cancer mortality in women under the age of 25, which is likely due to the introduction of the HPV vaccine.